Marshall Wace, LLP Brainsway Ltd. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Brainsway Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 112,925 shares of BWAY stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,925
Previous 84,926
32.97%
Holding current value
$1.05 Million
Previous $515,000
102.52%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BWAY
# of Institutions
34Shares Held
3.28MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA900KShares$8.4 Million0.42% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny361KShares$3.37 Million0.01% of portfolio
-
Essex Investment Management CO LLC Boston, MA348KShares$3.24 Million0.6% of portfolio
-
Acadian Asset Management LLC Boston, MA295KShares$2.75 Million0.01% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA251KShares$2.35 Million0.6% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $154M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...